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ABSTRACT 
Signal transduction pathways are constitutively expressed in leukaemic cells resulting in 
aberrant survival of the cells. It is postulated that in cells of chemo-sensitive patients, 
chemotherapy induces apoptotic signals leading to cell death while survival signals are 
maintained in cells of chemoresistant patients. There is very little information currently, on 
the expression of these mediators in patients immediately after chemotherapy initiation. We 
examined the expression pattern of proinfl ammatory cytokines, signaling molecules of the 
PI3K and MAPK pathways molecules and death receptor, DR5 on paired samples at 
diagnosis and during chemotherapy in acute myeloid leukaemia patients treated with cytosine 
arabinoside and daunorubicin. The results were correlated with remission status one month 
after chemotherapy. We found that in chemo-sensitive patients, chemotherapy signifi cantly 
increased the percentage of cases expressing TNF-α (p=0.025, n=9) and IL-6 (p=0.002, n=11) 
compared to chemo-resistant cases. We also observed an increased percentage of chemo-
sensitive cases expressing DR5 and phosphorylated p38, and Jnk. Thus, expression of TNF-α, 
IL-6, DR5, phospho-p38 and phospho-Jnk may regulate cell death in chemo-sensitive cases. 
In contrast, a signifi cantly higher percentage of chemo-resistant cases expressed phospho-
Bad (p=0.027, n=9). IL-1β and IL-18 were also found to be higher in chemo-resistant cases at 
diagnosis and during chemotherapy. Thus, expression of various cellular molecules in 
leukaemic blasts during chemotherapy may be useful in predicting treatment outcome. These 
cellular molecules may also be potential targets for alternative therapy. 
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